Ossip Groth: Die Seite wurde neu angelegt: „Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Siehe auch''' | align="left" width="800" | |- | bgcolor="#d…“

2010-03-09T17:42:59Z

Die Seite wurde neu angelegt: „miniatur|Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Siehe auch''' | align="left" width="800" | |- | bgcolor="#d…“

Neue Seite

[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]
{| class="wikitable" |
| bgcolor="#dfdfdf" | '''Siehe auch'''
| align="left" width="800" |
|-
| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''
| align="left" width="800" |<ref name="PMID11245588">Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280(4):C719-41 (2001) PMID 11245588 </ref><ref name="PMID16632549">Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291(3):H985-1002 (2006) PMID 16632549 </ref><ref name="PMID11514262">Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 281(3):H981-6 (2001) PMID 11514262 </ref><ref name="PMID11356602">Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction? Am J Physiol Heart Circ Physiol 280(6):H2484-8 (2001) PMID 11356602 </ref><ref name="PMID15821252">Endothelial cell dysfunction: can't live with it, how to live without it. Am J Physiol Renal Physiol 288(5):F871-80 (2005) PMID 15821252 </ref><ref name="PMID16504104">Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 5():4 (2006) PMID 16504104 </ref><ref name="PMID19225203">Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J 73(4):595-601 (2009) PMID 19225203 </ref><ref name="PMID17353456">Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10):1285-95 (2007) PMID 17353456 </ref><ref name="PMID14581385">Endothelial dysfunction. Circulation 108(17):2060-1 (2003) PMID 14581385 </ref><ref name="PMID14581384">Endothelial function testing as a biomarker of vascular disease. Circulation 108(17):2054-9 (2003) PMID 14581384 </ref><ref name="PMID11547217">Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Diabetes Metab 27(4 Pt 1):436-47 (2001) PMID 11547217 </ref><ref name="PMID11547216">Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function. Diabetes Metab 27(4 Pt 1):425-34 (2001) PMID 11547216 </ref><ref name="PMID15772232">Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques. Heart 91(4):553-8 (2005) PMID 15772232 </ref><ref name="PMID18299483">One step beyond: glutathione peroxidase and endothelial dysfunction. Hypertension 51(4):825-6 (2008) PMID 18299483 </ref><ref name="PMID18071058">Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation. Hypertension 51(1):31-2 (2008) PMID 18071058 </ref><ref name="PMID17309954">Methods for evaluating endothelial function in humans. Hypertension 49(4):748-60 (2007) PMID 17309954 </ref><ref name="PMID15284284">Endothelial dysfunction. J Am Soc Nephrol 15(8):1983-92 (2004) PMID 15284284 </ref><ref name="PMID14522472">The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42(7):1149-60 (2003) PMID 14522472 </ref><ref name="PMID10483941">Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 34(3):631-8 (1999) PMID 10483941 </ref><ref name="PMID9247501">Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 30(2):325-33 (1997) PMID 9247501 </ref>
|-
| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Medline Suchterm/ Synonyme'''
| align="left" width="800"|
|-
| bgcolor="#00dfdf" | '''Was ist das'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Struktur'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Physiologie'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Knockout'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Transgen'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Mutation'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Polymorphismus'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Genexpression'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Inhibitoren'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Agonisten'''
| align="left" width="800"|
|}

----

== Bibliographie ==
<references />

{{LinkWP_Miniartikel|Txt=Endotheliale Dysfunktion|Link=?}}

Endotheliale Dysfunktion - Versionsgeschichte

Ossip Groth: Die Seite wurde neu angelegt: „Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Siehe auch''' | align="left" width="800" | |- | bgcolor="#d…“